Here's why the ANZ (ASX:ANZ) share price is underperforming today

The Australia and New Zealand Banking GrpLtd (ASX:ANZ) share price is underperforming its peers on Monday. Here's why…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Australia and New Zealand Banking GrpLtd (ASX: ANZ) share price is underperforming its peers on Monday.

At the time of writing, the banking giant's shares are up ever so slightly to $26.22. This compares to a 1% gain by the Commonwealth Bank of Australia (ASX: CBA) share price.

a woman

Why is the ANZ share price underperforming?

This morning ANZ released an update in relation to news that AmBank has made an agreement with the Malaysian Ministry of Finance to resolve potential claims relating to its involvement with 1Malaysia Development Berhad (1MDB).

According to Reuters, the Malaysian bank will pay the government 2.83 billion ringgit (~US$700 million) to settle claims linked to a massive financial scandal at 1MDB.

1MDB is a state fund set up in 2009 by former prime minister Najib Razak. AmBank has been under investigation for its role in the alleged theft of US$4.5 billion from 1MDB.

Mr Najib was also under investigation and ultimately found guilty of corruption and money laundering over the transfer of millions of dollars linked to a 1MDB unit into his AmBank accounts between 2014 and 2015. Though, the former prime minister denies any wrongdoing and has filed an appeal.

In response to the agreement, AmBank said: "While this will have a material impact on the current year's profitability, there are adequate capital buffers to absorb this settlement without an immediate need to raise additional equity capital."

The finance ministry will also require AmBank to take corrective measures, as part of the settlement. This includes putting in place systems and processes to strengthen its due diligence framework.

How does this impact ANZ?

This morning ANZ revealed that the impact on its CET1 capital position will be neutral given its investments in associates are already a full deduction to capital.

However, the financial impact on ANZ of $212 million will be recorded as part of the equity accounted earnings from AmBank in its first half accounts. This will reduce the carrying value of ANZ's interest in AmBank from ~$1.050 billion to ~$850 million.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ASX Share Market News

Pilot on the phone looking distraught.
Broker Notes

Sell alert! Why this expert is ditching Qantas shares for this ASX 200 defence stock

A leading expert is selling Qantas shares and buying this surging ASX 200 defence stock instead. But why?

Read more »

An old-fashioned news boy stands on a stool and yells through a microphone in an open field.
ASX Share Market News

Why is everyone talking about Domino's, Light & Wonder and BHP shares on Wednesday?

BHP, Light & Wonder, and Domino’s shares are turning heads today. But why?

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

A leading expert forecasts more outperformance from the surging Pro Medicus share price.

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
ASX Share Market News

Earnings preview: can Cochlear shares rebound?

A decade low share price meets a make-or-break result.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Broker Notes

Morgans tips a 600%+ return for this ASX biotech stock

Good clinical study progress has the broker bullish on this company.

Read more »

Wlorker on a laptop on top of solar panels.
Broker Notes

Up 8%, should I buy the rebound in Origin Energy shares today?

A leading analyst provides his forecast for Origin Energy’s rebounding shares.

Read more »

Smiling man with phone in wheelchair watching stocks and trends on computer
ASX Share Market News

5 things to watch on the ASX 200 on Wednesday

Will it be a good hump day for Aussie investors? Let's find out.

Read more »